Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 3Solid Tumor 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Adenocarcinoma 1

Interventions

Gemcitabine 74Paclitaxel 60Capecitabine 60Fluorouracil 58Oxaliplatin 57Docetaxel 51Bevacizumab 51Leucovorin 48Nivolumab 41Irinotecan 40Cisplatin 40Carboplatin 37Cetuximab 34Radiosurgery 33pembrolizumab 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Albumin-Bound Paclitaxel 21Pemetrexed 20Doxorubicin 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × LY3022855 × Clear all
NCT02265536 2024-10-28

A Study of LY3022855 In Participants With Breast or Prostate Cancer

Eli Lilly and Company

Phase 1 Completed
34 enrolled 17 charts
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡